rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Frequency Electronics, Inc.

FEIM · Nasdaq

Health CareLife-science toolsIn trendDefense-TechSpace Economy

FEIM stood above a rising 150-day average in 51 of the last 52 weekly readings, including each of the last 30 weeks. It is 0.3% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
In trend
Weeks in an uptrend
30 in a row
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$75.0M
Officials’ trades on record
0
Institutions holding
135 (+14)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 51 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$72.3M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months2
Buyers · sellers0 · 2
WhoDidSharesTraded
Edenbrook Capital, LlcDirector, 10% ownersold97,826at $57.5028 Jul 2026filed 30 Jul 2026
Edenbrook Capital, LlcDirector, 10% ownersold554,348at $57.5028 Jul 2026filed 30 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders135+14 on the quarter
New · exited27 · 12
Reported value$479.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Edenbrook Capital, LLCunchanged · filed 13 Aug 20261,873,810$124.3M00.0%
Driehaus Capital Management LLCadded · filed 14 Aug 2026706,207$46.9M+214,306+43.6%
BlackRock, Inc.added · filed 7 Aug 2026516,548$34.3M+41,670+8.8%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026291,902$19.4M+9,461+3.3%
NEXT CENTURY GROWTH INVESTORS LLCadded · filed 14 Aug 2026230,728$15.3M+14,354+6.6%
DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026228,382$15.1M-29,020−11.3%
GOLDMAN SACHS GROUP INCreduced · filed 14 Aug 2026205,589$13.6M-59,092−22.3%
SEGALL BRYANT & HAMILL, LLCnew · filed 12 Aug 2026204,213$13.5M+204,213
G2 Investment Partners Management LLCadded · filed 14 Aug 2026202,655$13.4M+90,366+80.5%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026177,998$11.8M+17,656+11.0%
31 Mar 2023 – 30 Jun 2026
2477131Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Thomas McClelland Company insiderPresident and CEO · last 9 Sep 20260 · 15
Steven Lawrence Bernstein Company insiderCFO · last 31 Jul 20260 · 0
Edenbrook Capital, LLC Company insiderDirector, 10% owner · last 28 Jul 202628 · 1
Edenbrook Long Only Value Fund, Lp Company insiderDirector, 10% owner · last 28 Jul 202641 · 1
Oleandro Mancini Company insiderSr. VP Business Development · last 23 Apr 20250 · 2
Richard Schwartz Company insiderDirector · last 17 Apr 20250 · 0
Russell M. Sarachek Company insiderDirector · last 27 Mar 202519 · 0
Jonathan Brolin Company insiderDirector, 10% owner · last 31 Oct 202429 · 0
Lance W. Lord Company insiderDirector · last 31 Oct 20240 · 0
Adrian Lalicata Company insiderVP of RF and Microwave Systems · last 1 Nov 20210 · 3
John Patrick Caulfield Company insiderVP of Manufacturing · last 1 Nov 20210 · 0
Steven E. Strang Company insiderPresident FEI-Zyfer · last 1 Nov 20211 · 4

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2026 · to 30 Apr 202629.1%
Operating profit marginFY 2026 · to 30 Apr 2026-4.7%
Free cash flow marginFY 2026 · to 30 Apr 2026-2.5%
Return on capital employedFY 2026 · to 30 Apr 2026-4.3%
Interest coverFY 2026 · to 30 Apr 2026-34.49×
Research spendFY 2026 · to 30 Apr 20269.5%
Share count trendFY 2026 · to 15 Jul 20260.0%
Cash and equivalentsFY 2026 · to 30 Apr 2026$1.6M
Free cash flowFY 2026 · to 30 Apr 2026−$1.6M

Analyst forecasts

No analyst forecasts yet.